Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

When Heart Devices Fail, Who Should Be Blamed?
NY Times, NY
Wednesday, April 21, 2010 - 10:50am
tags:
Guidant, devices, Boston Scientific, defibrillators
District Court Denies Teva's Motion to Stay Integrelin Case
Seeking Alpha
Wednesday, April 21, 2010 - 10:27am
tags:
Teva Pharmaceuticals, Integrilin, ANDAs, Millennium
New Novartis chief talks productivity
Fierce Pharma
Wednesday, April 21, 2010 - 10:25am
tags:
Novartis, reorganization, Joe Jimenez, Pharma CEOs
One Strategic Purchase Makes Pharma Shine (Warner Chilcott)
Investors.com
Wednesday, April 21, 2010 - 10:23am
tags:
Warner Chilcott
New Rules on Medicaid Discounts a Bummer for States
WSJ Online
Wednesday, April 21, 2010 - 9:56am
tags:
Medicaid, healthcare reform
Gilead leads drug stocks south
Marketwatch
Wednesday, April 21, 2010 - 9:55am
tags:
Gilead Sciences, drug stocks
Elan moves closer to profitability
FT.com
Wednesday, April 21, 2010 - 9:53am
tags:
Elan, earnings
[video]Sinovac Biotech: China Watch
TheStreet.com
Wednesday, April 21, 2010 - 9:46am
tags:
Sinovac, China, biotech
Valeant to Acquire Pharmaceutical Company in Brazil
Yahoo
Wednesday, April 21, 2010 - 9:44am
tags:
Valeant Pharmaceuticals, Brazil, M&A
Rexahn Should Run Again
Seeking Alpha
Wednesday, April 21, 2010 - 9:38am
tags:
Rexahn, Teva Pharmaceuticals, Serdaxin
Abbott reports lower profit due to year-ago gain
Marketwatch
Wednesday, April 21, 2010 - 9:37am
tags:
Abbott Laboratories, earnings
Human Genome Sciences Down, But Not Out
Seeking Alpha
Wednesday, April 21, 2010 - 7:56am
tags:
Human Genome Sciences, GSK, Benlysta
NicOx Shares Rise as Natixis Sees Promise in Arthritis Therapy
Bloomberg
Wednesday, April 21, 2010 - 7:55am
tags:
NicOx, arthritis
Gilead Sags Despite Q1 Beat; Sees Cost from Health Reform
Barron's
Wednesday, April 21, 2010 - 7:53am
tags:
Gilead Sciences, earnings
Better, Targeted Drugs, Dead Ahead
Motley Fool
Wednesday, April 21, 2010 - 7:53am
tags:
personalized medicine, Vectibix, Amgen, Novartis, Bristol-Myers Squibb, Eli Lilly, OSI Pharmaceuticals, ONYX Pharmaceuticals, Roche
J&J: FDA rejects highly touted anesthesia system
Yahoo/AP
Tuesday, April 20, 2010 - 5:09pm
tags:
JNJ, FDA, anesthesia
Yasmin, Yaz Birth Control Subject of Lawsuits
WSJ Online
Tuesday, April 20, 2010 - 5:08pm
tags:
birth control pill, Yaz, Yasmin, lawsuits, Bayer
Obama Ate My Profits! Lilly Blames Cost of Health Reform, But the Company's Problems Are Its Own Fault
BNET Pharma
Tuesday, April 20, 2010 - 5:07pm
tags:
Obama, Eli Lilly, earnings, healthcare reform
Warning On Pediatric Trials of Pfizer Antipsychotic
WSJ Online
Tuesday, April 20, 2010 - 5:06pm
tags:
Pfizer, FDA, warnings, Geodon, pediatrics, clinical trials, antipsychotics
2 Smallcap Biotech Stocks to Watch
Seeking Alpha
Tuesday, April 20, 2010 - 10:57am
tags:
biotech, Delcath, Curis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.